Breaking News Instant updates and real-time market news.

RIOFF

Rio2 Limited

/

+

10:49
07/06/22
07/06
10:49
07/06/22
10:49

Rio2 Limited price target lowered to C$0.15 from C$0.40 at Raymond James

Raymond James analyst Craig Stanley lowered the firm's price target on Rio2 Limited to C$0.15 from C$0.40 and keeps a Market Perform rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Unity Biotechnology announces anticipated milestones » 07:17
08/12/22
08/12
07:17
08/12/22
07:17
UBX

Unity Biotechnology

/

+

UBX1325 24-week safety…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
12/15/21 Wedbush
Wedbush bullish on Unity Biotechnology, initiates with an Outperform
UBX Unity Biotechnology
/

+

Hot Stocks
PLx Pharma announces survey data on VAZALORE 81 mg » 07:17
08/12/22
08/12
07:17
08/12/22
07:17
PLXP

PLx Pharma

$2.59 /

+0.015 (+0.58%)

PLx Pharma, with its lead…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

03/15/22 BWS Financial
BWS drops coverage of PLx Pharma, says off Amazon again
12/07/21 Raymond James
Raymond James upgrades PLx Pharma on 'compelling entry point'
12/07/21 Raymond James
PLx Pharma upgraded to Outperform from Market Perform at Raymond James
11/12/21 JMP Securities
PLx Pharma reported strong quarter for Vazalore, says JMP Securities
PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

Hot Stocks
Unity Biotechnology expects cash to fund operations through 1Q23 » 07:17
08/12/22
08/12
07:17
08/12/22
07:17
UBX

Unity Biotechnology

/

+

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
12/15/21 Wedbush
Wedbush bullish on Unity Biotechnology, initiates with an Outperform
UBX Unity Biotechnology
/

+

Recommendations
Illumina price target lowered to $300 from $480 at Stifel » 07:16
08/12/22
08/12
07:16
08/12/22
07:16
ILMN

Illumina

$227.64 /

+0.44 (+0.19%)

Stifel analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

06:59 Today Citi
Illumina price target lowered to $200 from $220 at Citi
06:36 Today Baird
Illumina price target lowered to $215 from $306 at Baird
08/11/22 Piper Sandler
Illumina miss 'surprising' given backlog, says Piper Sandler
07/14/22 Canaccord
Illumina merger challenge not reflection of merits, says Canaccord
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

Earnings
Unity Biotechnology reports Q2 EPS (19c) vs. (32c) last year » 07:16
08/12/22
08/12
07:16
08/12/22
07:16
UBX

Unity Biotechnology

/

+

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBX Unity Biotechnology
/

+

UBX Unity Biotechnology
/

+

05/17/22 Citi
Unity Biotechnology price target lowered to $5 from $6 at Citi
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy at Roth Capital on 2022 clinical plans
01/04/22 Roth Capital
Unity Biotechnology upgraded to Buy from Neutral at Roth Capital
12/15/21 Wedbush
Wedbush bullish on Unity Biotechnology, initiates with an Outperform
UBX Unity Biotechnology
/

+

Recommendations
CS Disco price target lowered to $30 from $40 at Stifel » 07:15
08/12/22
08/12
07:15
08/12/22
07:15
LAW

CS Disco

$28.96 /

+0.39 (+1.37%)

Stifel analyst J. Parker…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

LAW CS Disco
$28.96 /

+0.39 (+1.37%)

06:15 Today BofA
CS Disco downgraded to Neutral from Buy at BofA
06:05 Today Canaccord
CS Disco downgraded to Hold from Buy at Canaccord
05:40 Today Cowen
Cowen cuts CS Disco to Market Perform as momentum hits 'big snag'
05:35 Today Cowen
CS Disco downgraded to Market Perform from Outperform at Cowen
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

  • 15
    Sep
LAW CS Disco
$28.96 /

+0.39 (+1.37%)

Earnings
Real Good Food raises FY22 revenue $155M-$160M from $150M-$160M » 07:15
08/12/22
08/12
07:15
08/12/22
07:15
RGF

Real Good Food

$6.93 /

-0.11 (-1.56%)

FY22 revenue consensus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RGF Real Good Food
$6.93 /

-0.11 (-1.56%)

RGF Real Good Food
$6.93 /

-0.11 (-1.56%)

03/08/22 Roth Capital
Real Good Food initiated with a Buy at Roth Capital
11/30/21
Fly Intel: Top five analyst initiations
11/30/21 Jefferies
Jefferies starts Real Good Food at Buy, sees 75% upside in 12 months
11/30/21 Truist
Real Good Food initiated with a Buy at Truist
RGF Real Good Food
$6.93 /

-0.11 (-1.56%)

  • 05
    Nov
General news
Market Update: » 07:15
08/12/22
08/12
07:15
08/12/22
07:15
$ECON

Economic Data

/

+

Market Update: Stock…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
Venus Concept sees 2022 revenue $110M-$113M, consensus $126.82M » 07:14
08/12/22
08/12
07:14
08/12/22
07:14
VERO

Venus Concept

/

+

The Company now expects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VERO Venus Concept
/

+

VERO Venus Concept
/

+

06/24/22 BTIG
Venus Concept price target lowered to $5.50 from $7.00 at BTIG
11/12/21 Stifel
Venus Concept price target trimmed to $2 at Stifel after Q3 miss
VERO Venus Concept
/

+

Earnings
Venus Concept reports Q2 EPS (16c), consensus (7c) » 07:14
08/12/22
08/12
07:14
08/12/22
07:14
VERO

Venus Concept

/

+

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VERO Venus Concept
/

+

VERO Venus Concept
/

+

06/24/22 BTIG
Venus Concept price target lowered to $5.50 from $7.00 at BTIG
11/12/21 Stifel
Venus Concept price target trimmed to $2 at Stifel after Q3 miss
VERO Venus Concept
/

+

Downgrade
Cellebrite downgraded to Market Perform at William Blair after guidance cut » 07:14
08/12/22
08/12
07:14
08/12/22
07:14
CLBT

Cellebrite

$5.28 /

-0.4 (-7.04%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

06:06 Today William Blair
Cellebrite downgraded to Market Perform from Outperform at William Blair
05/16/22 Cowen
Cellebrite price target lowered to $13 from $17 at Cowen
05/13/22 Deutsche Bank
Cellebrite price target lowered to $10 from $11 at Deutsche Bank
02/24/22 JPMorgan
Cellebrite initiated with an Overweight at JPMorgan
CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

Earnings
Real Good Food reports Q2 revenue $30.809M, consensus $32.12M » 07:14
08/12/22
08/12
07:14
08/12/22
07:14
RGF

Real Good Food

$6.93 /

-0.11 (-1.56%)

"I am pleased with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RGF Real Good Food
$6.93 /

-0.11 (-1.56%)

RGF Real Good Food
$6.93 /

-0.11 (-1.56%)

03/08/22 Roth Capital
Real Good Food initiated with a Buy at Roth Capital
11/30/21
Fly Intel: Top five analyst initiations
11/30/21 Jefferies
Jefferies starts Real Good Food at Buy, sees 75% upside in 12 months
11/30/21 Truist
Real Good Food initiated with a Buy at Truist
RGF Real Good Food
$6.93 /

-0.11 (-1.56%)

  • 05
    Nov
Syndicate
Vigil Neuroscience announces $75M private placement finanicng » 07:13
08/12/22
08/12
07:13
08/12/22
07:13
VIGL

Vigil Neuroscience

$7.29 /

+0.13 (+1.82%)

Vigil Neuroscience…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIGL Vigil Neuroscience
$7.29 /

+0.13 (+1.82%)

VIGL Vigil Neuroscience
$7.29 /

+0.13 (+1.82%)

02/01/22 Morgan Stanley
Morgan Stanley starts Vigil at Equal Weight ahead of 2023 derisking catalysts
02/01/22 Stifel
Stifel starts Vigil Neuroscience at Buy with $24 price target
02/01/22 Guggenheim
Vigil Neuroscience initiated with a Buy at Guggenheim
02/01/22 Stifel
Vigil Neuroscience initiated with a Buy at Stifel
VIGL Vigil Neuroscience
$7.29 /

+0.13 (+1.82%)

  • 07
    Jan
VIGL Vigil Neuroscience
$7.29 /

+0.13 (+1.82%)

Recommendations
Brilliant Earth price target raised to $10 from $8 at KeyBanc » 07:13
08/12/22
08/12
07:13
08/12/22
07:13
BRLT

Brilliant Earth

$6.44 /

-0.17 (-2.57%)

KeyBanc analyst Noah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRLT Brilliant Earth
$6.44 /

-0.17 (-2.57%)

BRLT Brilliant Earth
$6.44 /

-0.17 (-2.57%)

07/22/22 Piper Sandler
Brilliant Earth downgraded to Neutral from Overweight at Piper Sandler
07/21/22 KeyBanc
KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view
07/20/22 KeyBanc
Brilliant Earth initiated with an Overweight at KeyBanc
06/29/22 Raymond James
Brilliant Earth initiated with an Outperform at Raymond James
BRLT Brilliant Earth
$6.44 /

-0.17 (-2.57%)

  • 23
    Sep
BRLT Brilliant Earth
$6.44 /

-0.17 (-2.57%)

Earnings
Aslan Pharmaceuticals reports Q2 EPS (4c) vs (2c) last year » 07:12
08/12/22
08/12
07:12
08/12/22
07:12
ASLN

Aslan Pharmaceuticals

/

+

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASLN Aslan Pharmaceuticals
/

+

ASLN Aslan Pharmaceuticals
/

+

05/23/22 Piper Sandler
Aslan Pharmaceuticals price target lowered to $3 from $8 at Piper Sandler
09/27/21 Piper Sandler
Piper buyers on Aslan weakness, thinks ASLAN-004 can be competitive
ASLN Aslan Pharmaceuticals
/

+

Earnings
Gencor Industries reports Q3 EPS (7c) vs. 16c last year » 07:12
08/12/22
08/12
07:12
08/12/22
07:12
GENC

Gencor Industries

$9.57 /

-0.08 (-0.83%)

Reports Q3 revenue $29.6M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GENC Gencor Industries
$9.57 /

-0.08 (-0.83%)

GENC Gencor Industries
$9.57 /

-0.08 (-0.83%)

Recommendations
Chicken Soup for the Soul price target raised to $52 from $40 at DA Davidson » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
CSSE

Chicken Soup for the Soul

/

+

, RDBX

Redbox

$1.71 /

+ (+0.00%)

, ROKU

Roku

$80.65 /

-0.33 (-0.41%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSSE Chicken Soup for the Soul
/

+

RDBX Redbox
$1.71 /

+ (+0.00%)

ROKU Roku
$80.65 /

-0.33 (-0.41%)

CSSE Chicken Soup for the Soul
/

+

07/12/22 B. Riley
Chicken Soup sees positive free cash flow by year-end, says B. Riley
06/14/22 DA Davidson
DA Davidson likes Chicken Soup for the Soul amid strong box office, Redbox deal
05/27/22 B. Riley
Redbox downgraded to Sell from Neutral at B. Riley
05/17/22 Guggenheim
Chicken Soup for the Soul resumed with a Buy at Guggenheim
RDBX Redbox
$1.71 /

+ (+0.00%)

07/12/22 B. Riley
Chicken Soup sees positive free cash flow by year-end, says B. Riley
06/14/22 DA Davidson
DA Davidson likes Chicken Soup for the Soul amid strong box office, Redbox deal
05/27/22 B. Riley
Redbox downgraded to Sell from Neutral at B. Riley
05/17/22 Guggenheim
Chicken Soup for the Soul resumed with a Buy at Guggenheim
ROKU Roku
$80.65 /

-0.33 (-0.41%)

08/10/22 MoffettNathanson
MoffettNathanson downgrades Roku to sell on 'challenged' position
08/10/22 MoffettNathanson
Roku downgraded to Underperform from Market Perform at MoffettNathanson
08/08/22 Pivotal Research
Roku downgraded to Sell from Hold at Pivotal Research
08/03/22 Citi
Roku price target lowered to $125 from $165 at Citi
CSSE Chicken Soup for the Soul
/

+

ROKU Roku
$80.65 /

-0.33 (-0.41%)

ROKU Roku
$80.65 /

-0.33 (-0.41%)

CSSE Chicken Soup for the Soul
/

+

RDBX Redbox
$1.71 /

+ (+0.00%)

ROKU Roku
$80.65 /

-0.33 (-0.41%)

CSSE Chicken Soup for the Soul
/

+

RDBX Redbox
$1.71 /

+ (+0.00%)

ROKU Roku
$80.65 /

-0.33 (-0.41%)

Downgrade
Allegiant Travel downgraded to Peer Perform from Outperform at Wolfe Research » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
ALGT

Allegiant Travel

$107.03 /

-0.12 (-0.11%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

07:00 Today Wolfe Research
Allegiant Travel downgraded to Peer Perform from Outperform at Wolfe Research
08/10/22 Barclays
Allegiant Travel price target lowered to $150 from $180 at Barclays
08/04/22 Deutsche Bank
Allegiant Travel price target lowered to $190 from $245 at Deutsche Bank
07/26/22 Susquehanna
Allegiant Travel negative reveal suggests price sensitivity, says Susquehanna
ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

Hot Stocks
HCW Biologics expects cash to fund operations through end of 2023 » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
HCWB

HCW Biologics

$2.04 /

-0.21 (-9.33%)

On June 30, 2022, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

03/24/22 Maxim
HCW Biologics initiated with a Buy at Maxim
03/24/22 Maxim
HCW Biologics initiated with a Buy at Maxim
HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

Earnings
HCW Biologics reports Q2 EPS (66c) vs (10c) last year » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
HCWB

HCW Biologics

$2.04 /

-0.21 (-9.33%)

Reports Q2 revenue $0 vs…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

03/24/22 Maxim
HCW Biologics initiated with a Buy at Maxim
03/24/22 Maxim
HCW Biologics initiated with a Buy at Maxim
HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

Earnings
Silver Spike Investment reports Q1 NII 4c vs. ($425.03) last year » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
SSIC

Silver Spike Investment

$8.86 /

-0.33 (-3.59%)

Net asset value per share…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSIC Silver Spike Investment
$8.86 /

-0.33 (-3.59%)

03/01/22 Piper Sandler
Silver Spike Investment initiated with an Overweight at Piper Sandler
03/01/22 Stifel
Silver Spike Investment initiated with a Hold at Stifel
  • 04
    Feb
Earnings
Instil Bio reports Q2 adjusted EPS (40c), consensus (41c) » 07:08
08/12/22
08/12
07:08
08/12/22
07:08
TIL

Instil Bio

$6.79 /

+0.09 (+1.34%)

As of June 30, 2022, we…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

06/05/22 Morgan Stanley
Instil Bio price target lowered to $9 from $14 at Morgan Stanley
08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

Hot Stocks
Rapid Micro Biosystems adopts stockholder rights plan » 07:08
08/12/22
08/12
07:08
08/12/22
07:08
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Rapid Micro Biosystems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Hot Stocks
Rapid Micro Biosystems announces review of strategic alternatives » 07:07
08/12/22
08/12
07:07
08/12/22
07:07
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Rapid Micro Biosystems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Recommendations
Marriott Vacations price target lowered to $202 from $205 at Truist » 07:07
08/12/22
08/12
07:07
08/12/22
07:07
VAC

Marriott Vacations

$146.63 /

+1.64 (+1.13%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VAC Marriott Vacations
$146.63 /

+1.64 (+1.13%)

VAC Marriott Vacations
$146.63 /

+1.64 (+1.13%)

08/10/22 Barclays
Marriott Vacations price target raised to $165 from $136 at Barclays
08/10/22 Deutsche Bank
Marriott Vacations price target raised to $192 from $188 at Deutsche Bank
06/28/22 Barclays
Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names
06/28/22 Barclays
Marriott Vacations initiated with an Overweight at Barclays
VAC Marriott Vacations
$146.63 /

+1.64 (+1.13%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.